...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

narmac - One thing I really like about ZCC, Ken Dart owns about 38% of it. Those are the same class of shares that you and I own. That's a lot of clout to make sure things are on the up and up for that class of shares. Dart has been known to take countries to court, management of this company would be no issue. For what it's worth though, my personal opinion is that we will not have to be concerned about any shadiness.

tada 

Share
New Message
Please login to post a reply